An honest comparison

Ozempic / Wegovy (Semaglutide) vs Phentermine

Ozempic / Wegovy (Semaglutide) and Phentermine both target weight loss and metabolic health — but through different mechanisms, with different evidence bases, and for different populations. The honest comparison favours one over the other only for specific reader profiles; for many adults, the right answer is "neither, here's what fits."

At a glance

MetricOzempic / Wegovy (Semaglutide)Phentermine
Sustainability6/103/10
Short-term effect9/106/10
Long-term effect7/104/10
Cost / month~$1100~$30
Visible results~28 days~14 days
Evidence qualitystrongmoderate

Who should pick Ozempic / Wegovy (Semaglutide)

Ozempic / Wegovy (Semaglutide) fits adults who semaglutide is genuinely indicated for adults with bmi ≥30 (or ≥27 with comorbidities), particularly those with type-2 diabetes, established cardiovascular disease, prediabetes, or significant obesity-related comorbidity.

Who should pick Phentermine

Phentermine fits adults who adults with moderate obesity who can't access glp-1 drugs (cost, supply, insurance), as a short-term boost.

The honest verdict

Ozempic / Wegovy (Semaglutide) scores 6/10 on sustainability and 7/10 long-term, with strong evidence. Phentermine scores 3/10 sustainability and 4/10 long-term, with moderate evidence. Ozempic / Wegovy (Semaglutide) edges ahead long-term in our reading. The choice should be driven by which one you can actually sustain.

Why both might fail you (and what to do instead)

Both can fail when the underlying drivers (sleep, stress, ultra-processed-food saturation, metabolic adaptation in repeat dieters) aren't addressed. If you've already tried both or one and bounced, the issue isn't macros — it's protocol fit. The Metabolic Damage Assessment maps your profile to a starter protocol that addresses the actual gap.

Free · 2 minutes

Still not sure which fits?

The Metabolic Damage Assessment maps your profile to a starter protocol matched to your specific patterns — not a generic comparison.